NYSE · LLY
Eli Lilly and Company
$1,417.70+$44.00 (+3.2%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 2.21% below the high.
Loading market information…
OTC · MICR · USD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Micron Solutions, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.2% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Micron Solutions, Inc.’s forward annual dividend is $0.06 per share, paid semi-annual. The forward yield is 117.42% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Micron Solutions, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Micron Solutions, Inc. operates as a contract manufacturer, primarily serving the medical device, defense, and life sciences industries. The company's comprehensive offerings include precision machining, thermoplastic injection molding, and mold fabrication. They also provide sensors, orthopedic implants and related devices, and diagnostic test kits. Furthermore, Micron Solutions, Inc. develops specialized solutions for the medical, orthopedic, consumer, and automotive sectors. Established in 1978, the company is headquartered in Fitchburg, Massachusetts.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:00 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1,417.70+$44.00 (+3.2%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 2.21% below the high.
$274.78-$0.42 (-0.15%)
Johnson & Johnson’s quoted price sits in the upper half of its reported 52-week range, 2.56% below the high.
$294.38+$3.59 (+1.23%)
AbbVie Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.46% below the high.
$149.84+$3.51 (+2.4%)
Merck & Co., Inc.’s quoted price sits in the upper half of its reported 52-week range, 4.51% below the high.
$408.79-$2.13 (-0.52%)
UnitedHealth Group Incorporated’s quoted price sits in the upper half of its reported 52-week range, 11.45% below the high.
$693.16-$16.02 (-2.26%)
Thermo Fisher Scientific Inc.’s quoted price sits in the upper half of its reported 52-week range, 2.63% below the high.
$12.99-$0.22 (-1.63%)
Eloxx Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 44.51% below the high.
$0.00$0.00 (0.0%)
Cue Health Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
